Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
GLP-1s Don't Work for Everyone: What to Know If Not Seeing Results - Featured image
GLP-1 Medications

GLP-1s Don't Work for Everyone: What to Know If Not Seeing Results

Shotlee Editorial Team
Written by Shotlee Editorial TeamHealth Research & Writing
·April 22, 2026·7 min read

On this page

  • What Are GLP-1 Receptor Agonists and How Do They Work?
  • Common Reasons Your GLP-1 Isn't Delivering Results
  • The Genetic Factor: PAM Gene Variants and GLP-1 Response
  • Should You Get Tested for the PAM Gene?
  • Beyond Genetics: Other Key Factors Affecting GLP-1 Success
  • GLP-1 Alternatives If They're Not Working for You
  • Key Takeaways: What This Means for Patients
  • Conclusion: Personalized Paths to Metabolic Health
  • Metformin
  • SGLT2 Inhibitors
  • Protein-Fiber Focused Diet

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

Started GLP-1s for weight loss or blood sugar control but seeing no results? New research in Genome Medicine reveals that 10% of people carry PAM gene variants linked to weaker responses. Experts explain genetics, common pitfalls, testing, and effective alternatives to help you succeed.

Share

On this page

  • What Are GLP-1 Receptor Agonists and How Do They Work?
  • Common Reasons Your GLP-1 Isn't Delivering Results
  • The Genetic Factor: PAM Gene Variants and GLP-1 Response
  • Should You Get Tested for the PAM Gene?
  • Beyond Genetics: Other Key Factors Affecting GLP-1 Success
  • GLP-1 Alternatives If They're Not Working for You
  • Key Takeaways: What This Means for Patients
  • Conclusion: Personalized Paths to Metabolic Health
  • Metformin
  • SGLT2 Inhibitors
  • Protein-Fiber Focused Diet

If you've started a GLP-1 medication like semaglutide (Ozempic or Wegovy) or tirzepatide (Mounjaro) expecting improvements in blood sugar, weight loss, or appetite control, but months later, you're not seeing results, you're not alone. GLP-1s don't work for everyone, and understanding why—especially emerging genetic factors—can guide your next steps. This guide breaks down expert insights, a key study on the PAM gene, assessment timelines, testing options, and proven alternatives.

What Are GLP-1 Receptor Agonists and How Do They Work?

"GLP-1 receptor agonists are medications that mimic a natural hormone in your body called glucagon-like peptide-1 [GLP-1]," explains Thomas Tsang, MD, MPH, Chief Medical Officer at Omada Health. "From my perspective, these medications have an effect both on your brain and your metabolism because they act on areas that regulate appetite and reward while also affecting how your pancreas releases insulin and how quickly your stomach empties."

"Many people think about GLP-1s as weight loss drugs, but their benefits can go far beyond that to include improved blood sugar control, better heart health and decreased appetite," adds Dr. Tsang.

These injectable or oral GLP-1 drugs slow gastric emptying, signal fullness to the brain, and enhance insulin secretion in response to meals. For many with type 2 diabetes or obesity, they lead to 10-20% body weight loss and A1C reductions of 1-2%. However, individual responses vary due to factors like dosage, adherence, lifestyle, and now, genetics.

Common Reasons Your GLP-1 Isn't Delivering Results

Kardie Tobb, DO, MS, FASPC, FACC, a board-certified preventive cardiologist and the medical director for the Cone Health HeartCare Women's Heart Health and Cardio-Obstetrics Clinic, explains some of the most common reasons why GLP-1s may not deliver the results you're hoping for.

And just because your GLP-1 isn't working immediately doesn't mean it won't work for you. Dr. Tsang says using a GLP-1 requires practicing self-awareness and patience over time if you expect to lose weight and keep it off.

"You might notice that you have reduced appetite and food cravings and feel satisfied with smaller portions," says Dr. Tsang. "You might also notice improved blood sugar readings, better energy or mood and gradual weight loss. All these factors indicate that you possibly just need time or dose adjustment and likely should continue."

"However, if you have no reduction in appetite after eight to 12 weeks, no weight loss or blood sugar improvement after three to six months or persistent severe side effects that prevent you from going up in dosage, GLP-1s may not be for you," adds Dr. Tsang.

Other influences include suboptimal dosing (titration too slow), poor adherence to injection schedules, high insulin resistance from low muscle mass, inadequate sleep, or diet quality that counters the drug's effects. Tracking symptoms with apps like Shotlee can help monitor appetite changes, blood sugar trends, and side effects to discuss with your doctor.

The Genetic Factor: PAM Gene Variants and GLP-1 Response

New research points to a cause that might not be on your radar yet: your genes. In a study published in Genome Medicine, researchers found that about 10 percent of people carry certain variants of what's known as the PAM gene, and those individuals had a weaker blood sugar response to GLP-1-based drugs compared to non-carriers. This suggests the drugs may not work as well for them. And while the study focused on blood sugar control, experts say it may also help explain why some people don't see the same weight loss results on GLP-1s.

Why? Dr. Tobb explains that the PAM gene helps activate hormones like GLP-1 so they can work properly in the body. If you carry certain variants, your body may not process or "turn on" those hormones as efficiently, leading to weaker GLP-1 signaling. That means even if you're taking a GLP-1 medication for diabetes or weight management, the body's response, like insulin release, may be blunted. So the drug is there, but its full effect isn't.

This genetic insight underscores personalized medicine in metabolic health. While not everyone needs testing, it explains variability beyond lifestyle for non-responders.

Should You Get Tested for the PAM Gene?

If you're hearing about this gene for the first time, you may be wondering how to get tested and what it might cost. Dr. Tobb says the only way to identify a PAM gene variant is through genetic testing, since there are no symptoms or routine lab tests that can detect it. She says this is usually done through broader genetic panels ordered by a doctor, rather than testing for the gene on its own.

"Many cases require prior authorization or are not covered, and out-of-pocket costs generally range from a few hundred dollars for targeted panels to $1,000 to $2,000 for broader panels and several thousand dollars for whole exome or genome sequencing," says Dr. Tobb.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Discuss with your endocrinologist or primary care provider if persistent non-response warrants pharmacogenomic testing, often bundled in diabetes or obesity panels.

Beyond Genetics: Other Key Factors Affecting GLP-1 Success

And while Dr. Tobb says the PAM gene is an interesting example of how genetics can influence weight loss and blood sugar control, she says that most differences in results come down to factors like sleep, medication adherence, diet quality, muscle mass and overall insulin resistance.

To optimize outcomes, pair GLP-1s with resistance training to build muscle (boosting metabolism), 7-9 hours of sleep nightly, and consistent dosing. Side effects like nausea often improve with time or antiemetics, allowing dose escalation crucial for efficacy.

GLP-1 Alternatives If They're Not Working for You

If you find you're not responding to GLP-1s, or if you are seeing results and want to build on them, Dr. Tobb shares three GLP-1 alternatives that may help support blood sugar control and weight loss. Ask your doctor if one of these might be right for you.

Metformin

Metformin is a first-line oral medication for type 2 diabetes with a long history of data supporting its use. Dr. Tobb explains that it lowers glucose production in the liver and improves insulin sensitivity in the muscles, which can help stabilize blood sugar and helps reduce appetite in some people.

Pros: Affordable, weight-neutral or loss-promoting, low hypoglycemia risk. Cons: GI upset initially; not as potent for obesity alone.

SGLT2 Inhibitors

This is a once-daily pill that works to support weight loss through the kidneys rather than gut hormones. It helps the body expel excess glucose through urine, Dr. Tobb explains, leading to mild calorie loss, modest weight reduction and improved blood sugar control.

Examples include empagliflozin (Jardiance) or dapagliflozin (Farxiga). Added benefits: heart and kidney protection. Watch for UTIs or dehydration.

Protein-Fiber Focused Diet

Dr. Tobb says this eating approach emphasizes protein, fiber and minimally processed carbs and can complement the results you might see on weight loss medications. Protein helps increase satiety hormones, reduces blood sugar spikes after meals and supports muscle mass, which plays a key role in improving insulin sensitivity, she adds.

Aim for 1.6g protein/kg body weight daily, high-fiber veggies, and whole grains. This amplifies any medication's effects.

Key Takeaways: What This Means for Patients

  • Give GLP-1s 8-12 weeks for appetite effects, 3-6 months for weight/blood sugar changes.
  • 10% carry PAM gene variants blunting GLP-1 response per Genome Medicine study.
  • Genetic testing costs $200-$2000+; discuss with doctor for non-responders.
  • Lifestyle factors like sleep and muscle mass often drive differences more than genes.
  • Alternatives: Metformin, SGLT2s, protein-fiber diets offer solid options.

Conclusion: Personalized Paths to Metabolic Health

We get it. When a new health routine or medication seems to work beautifully for everyone else, it's natural to feel frustrated, or even isolated, when you're not seeing the same results. But here's the truth: Your body is unique, and that's not a flaw.

Understanding why your GLP-1 may not be working as expected is the first step toward finding what will work. Whether it's adjusting your dosage, giving it more time, exploring alternatives or working with your doctor to try a different approach, you have options to reach your weight-loss goals.

Consult your healthcare provider before changes, and consider related topics like natural diabetes prevention or phentermine considerations for comprehensive care.

?Frequently Asked Questions

Why isn't my GLP-1 medication like Ozempic working for weight loss?

Common reasons include insufficient time (wait 3-6 months), no dose escalation, lifestyle factors like poor sleep or diet, or genetic variants like PAM gene affecting hormone activation, seen in 10% per Genome Medicine study.

What is the PAM gene and its role in GLP-1 response?

The PAM gene activates hormones like GLP-1. Variants in 10% of people lead to weaker signaling, blunted insulin release, and poorer blood sugar/weight loss results on GLP-1 drugs.

How long should I try GLP-1s before considering alternatives?

Monitor for appetite reduction in 8-12 weeks; assess weight loss or blood sugar improvement after 3-6 months. Persistent lack of response or severe side effects may indicate switching.

What are good alternatives to GLP-1 medications?

Options include metformin (improves insulin sensitivity), SGLT2 inhibitors (expel glucose via urine for modest weight loss), and protein-fiber diets to boost satiety and insulin sensitivity.

How can I get tested for PAM gene variants?

Genetic testing via doctor-ordered panels; costs $200-$2000 out-of-pocket, often not covered without prior authorization. No routine labs detect it.

Source Information

Originally published by Aol.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

What's the Deal with Peptides? The Hyped Market Under FDA Review
Health & Wellness

What's the Deal with Peptides? The Hyped Market Under FDA Review

An in-depth look at the FDA's review of unregulated peptide therapy, the safety concerns raised by experts, and the conflict between industry demand and clinical evidence.

8 min read
Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program
Health & Wellness

Eli Lilly, Novo Nordisk Address Awareness Gap for Medicare’s $50 GLP-1 Program

Learn how the new Medicare GLP-1 Bridge program works, which drugs are covered, and why major pharmaceutical companies are leading the awareness push for the $50 copay initiative.

8 min read
Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials
Medical Research

Eli Lilly's Retatrutide Shows Cardiovascular and Diabetic Benefits in Trials

Eli Lilly's investigational drug, retatrutide, has shown promising results in clinical trials, offering substantial weight loss and significant improvements in cardiovascular health and type 2 diabetes management.

7 min read

Same topic: GLP-1 Agonists

All GLP-1 Agonists articles →
Samsung Biologics Acquires PolyPeptide for $1.8 Billion to Expand Peptide Therapeutics
Pharmaceutical Industry News

Samsung Biologics Acquires PolyPeptide for $1.8 Billion to Expand Peptide Therapeutics

Samsung Biologics has announced a major acquisition of PolyPeptide Group AG for $1.8 billion, marking a strategic expansion into the rapidly growing peptide therapeutics market, particularly for GLP-1 drugs.

8 min read
Fat Jabs Slash Alcohol-Related Hospitalisations by More Than a Quarter
Health

Fat Jabs Slash Alcohol-Related Hospitalisations by More Than a Quarter

Recent analysis indicates that GLP-1 weight loss medications significantly reduce the risk of alcohol-related hospital admissions by approximately 26 percent compared to other diabetes treatments.

8 min read
Doctors Warn a New GLP-1 Finding May Raise Your Risk of Smell Loss
Health

Doctors Warn a New GLP-1 Finding May Raise Your Risk of Smell Loss

Researchers analyzed nearly 877,000 patients and found a significant link between GLP-1 receptor agonists and sensory disturbances.

8 min read

More in GLP-1 Medications

Study: Ozempic, Wegovy NAION Risk Twofold Higher vs. SGLT2i Drugs
GLP-1 Medications

Study: Ozempic, Wegovy NAION Risk Twofold Higher vs. SGLT2i Drugs

New research from Veterans' Affairs shows Ozempic and Wegovy users face double the risk of NAION—a serious vision loss condition—compared to SGLT2i drugs. Published in JAMA Ophthalmology, the study urges doctors to warn patients about potential permanent blindness from semaglutide-based GLP-1 medications. As lawsuits mount, understand the implications for diabetes and weight management.

5 min read
How to Keep Weight Off After Ozempic: Proven Strategies
GLP-1 Medications

How to Keep Weight Off After Ozempic: Proven Strategies

Stopping Ozempic often leads to weight regain—up to 7% in trials or two-thirds within a year. While continuing semaglutide helps sustain losses, lifestyle changes and maintenance dosing offer alternatives. Work with your healthcare team for a personalized plan to keep the weight off long-term.

6 min read
Eli Lilly Eyes India Rollout for Oral Obesity Drug Orforglipron
GLP-1 Medications

Eli Lilly Eyes India Rollout for Oral Obesity Drug Orforglipron

US drugmaker Eli Lilly is set to bring orforglipron, a game-changing oral weight-loss pill, to India following successful global trials that included Indian patients. With obesity rates surging, this daily GLP-1 therapy promises easier access than injectables like Mounjaro. Explore the trial data, market insights, and what it means for patients.

5 min read
Share this article
  1. Home
  2. Blog
  3. GLP-1s Don't Work for Everyone: What to Know If Not Seeing Results
Shotlee Editorial Team — Health Research & Writing
Written by

Shotlee Editorial Team

Health Research & Writing

Shotlee’s guides and articles are researched and written in-house by the Shotlee Editorial Team. We build every page from primary sources — FDA labels, official prescribing information, and peer-reviewed clinical trials — and cite them directly. Our content is educational and is not a substitute for advice from your own healthcare provider.

View all articles by Shotlee Editorial Team
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community